Divide and Conquer With Debulking in Management of Rocky Hard Cataract
ConditionCataract Mature
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-100
SponsorSohag University
About this trial
The management of nucleus may be challenging in rocky hard cataracts. Hard cataracts are difficult to fragment, and the excessive energy required to emulsify the hard nucleus can result in complications such as corneal edema, inflammation, wound burn, posterior capsular rupture, and zonular dialysis. different surgical techniques are used for the management of hard cataracts, with their advantages and limitations. Divide and conquer with debulking is a new technique for management of rocky hard cataract.
In this research we assess its safety comparing it with standard divide and conquer technique.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
adults with rocky hard cataract
Disqualifiers
patients with abnormal endothelial cell count.
patients with glaucoma.
patients with retinal problems.
Trial design
Design model
Parallel
Treatments tested in this trial
cataract operation by phacoemulsification
Procedure/Surgeryphacoemulsification either by standard divide and conquer or divide and conquer with debulking.
Treatment groups
50 Participants
are divided into 2 treatment groupsGroup A: standard divide and conquerActive comparator 1 intervention
Group B: divide and conquer with debulkingExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
endothelial cell count
Time frame
3 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: